Comparison of vascularization of Medpor and Medpor-plus orbital implants: A prospective, randomized study

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 6, 2007, Pages 463-467

  Naik, Milind N ^a   Murthy, Ramesh K ^a   Honavar, Santosh G ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; POLYETHYLENE;

ADULT; ARTICLE; BONE GRAFT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; IMPLANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT IMPLANT; PARTICULATE MATTER; POROSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT DURATION; VASCULARIZATION;

ADOLESCENT; ADULT; BIOCOMPATIBLE MATERIALS; EYE ENUCLEATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; ORBITAL IMPLANTS; POLYETHYLENES; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION;

EID: 36348974018     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e318158ec8e     Document Type: Article

References (24)

1. Gougelmann HP. The evolution of the ocular motility implant. Int Ophthalmol Clin 1970;10:689-711.
2. Genevois O, Millet P, Retout A, Quintyn JC. Comparison after 10 years of two 100-patient cohorts operated on for eviscerations or enucleations. Eur J Ophthalmol 2004;14:363-8.
3. Perry AC. Integrated orbital implants. Adv Ophthal Plastic Reconstr Surg 1988;8:75-81.
4. Shields CL, Shields JA, Eagle RC Jr., De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 1991;111:363-6.
5. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-95.
6. Ferrone PJ, Dutton JJ. Rate of vascularization of coralline hydroxyapatite ocular implants. Ophthalmology 1992;99:376-9.
7. Shields CL, Shields JA, De Potter P. Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. Arch Ophthalmol 1992;110:333-8.
8. Rubin PAD, Popham JK, Bilyk JR, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:96-103.
9. Perry AC. Advances in enucleation. Ophthal Plast Reconstr Surg 1991;4:173-82.
10. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
11. Jordan DR, Brownstein S, Dorey M, et al. Fibrovascularization of porous polyethylene (Medpor) orbital implant in a rabbit model. Ophthal Plast Reconstr Surg 2004;20:136-43.
12. Chuah CT, Chee SP, Fong KS, et al. Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients. Ann Acad Med Singapore 2004;33:477-83.
13. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg 2004;20:274-80.
14. Jordan DR, Ahuja N, Gilberg S, Bouchard R. Behavior of various orbital implants under axial compression. Ophthal Plast Reconstr Surg 2005;21:225-9.
15. Zamet JS, Darbar UR, Griffiths GS, et al. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol 1997;24:410-8.
16. Wilson J, Clark AE, Hall M, Hench LI. Tissue response to bioglass endosseous ridge maintenance implants. J Oral Implantol 1993;19:295-302.
17. Price N, Bendall SP, Frondoza C, et al. Human osteoblast-like cells (MG63) proliferate on a bioactive glass surface. J Biomed Mater Res 1997;37:394-400.
18. Oonishi H, Kushitani S, Yasukawa E, et al. Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthopaedics 1997;334:316-25.
19. Keeting PE, Oursler MJ, Wiegand KE, et al. Zeolite A increases proliferation, differentiation, and transforming growth factor β production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 1992;7:1281-9.
20. Bosetti M, Zanardi L, Hench L, Cannas M. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res 2003;64:189-95.
21. Amato MM, Blaydon SM, Scribbick FW, et al. Use of bioglass for orbital volume augmentation in enophthalmos: a rabbit model (Oryctolagus cuniculus). Ophthal Plast Reconstr Surg 2003;19:455-65.
22. Choi HY, Lee JE, Park HJ, Oum BS. Effect of synthetic bone glass particulate on the fibrovascularization of porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 2006;22:121-5.
23. De Potter P, Shields CL, Shields JA, et al. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology 1992;99:824-30.
24. De Potter P, Duprez T, Cosnard G. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor). Ophthalmology 2000;107:1656-60.